Similar results were found in patients with COVID-19 and NTIS (27.5% of the total), who were characterized by higher levels of ESR, CRP and procalcitonin, and a lower lymphocyte count than in COVID-19 non-NTIS patients [91]. This evidence concerns the gene ESR1 and COVID-19.